Mechanisms of Tumor Cell Lysis by Natural Killer Cells

[1]  D. Redelman.  The mechanism of cell-mediated cytotoxicity. II. The apparent biochemical requirements for cytolysis are influenced by the source and frequency of murine cytotoxic T lymphocytes. , 1982, Cellular immunology.

[2]  R. Goldfarb.  Proteases in tumor invasion and metastasis , 1982 .

[3]  C. Evans.  The role of lymphotoxin in natural cell-mediated cytotoxicity. , 1981, Cellular immunology.

[4]  R. Goldfarb,et al.  Natural killer cell reactivity: regulatory interactions and among phorbol ester, interferon, cholera toxin, and retinoic acid. , 1981, Journal of immunology.

[5]  F. Hirata,et al.  Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Rittenhouse-Simmons.  Differential activation of platelet phospholipases by thrombin and ionophore A23187. , 1981, The Journal of biological chemistry.

[7]  D. Hart,et al.  Characterization of a plasma membrane-associated plasminogen activator on thymocytes. , 1981, Biochimica et biophysica acta.

[8]  B. Bonavida,et al.  Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes. , 1981, Journal of immunology.

[9]  T. Haverty,et al.  Inhibition of human natural cytotoxicity by macromolecular antiproteases. , 1981, Journal of immunology.

[10]  J. Maillard,et al.  Plasminogen activation by normal B lymphocytes, a function associated with the cell membrane. , 1981, Journal of immunology.

[11]  D. Adams,et al.  Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. , 1981, Journal of immunology.

[12]  J. Ortaldo,et al.  Characteristics of human large granular lymphocytes and relationship to natural killer and K cells , 1981, The Journal of experimental medicine.

[13]  S. Sharma,et al.  Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. 5. Role of proteases, inhibitors, and substrates. , 1980, Cellular immunology.

[14]  R. Goldfarb,et al.  Purification of plasminogen activator from Rous sarcoma virus transformed chick embryo fibroblasts treated with the tumor promoter phorbol 12-myristate 13-acetate. , 1980, Biochemistry.

[15]  D. Hart,et al.  Detection and partial characterization of lymphoid cell surface proteases. , 1980, Cellular immunology.

[16]  H. Bosch.  Intracellular phospholipases A. , 1980 .

[17]  C. Nathan,et al.  The macrophage as an effector cell. , 1980, The New England journal of medicine.

[18]  C. Prasad,et al.  Chymostatin inhibits cellular aggregation of activated human peripheral blood lymphocytes. , 1980, Life sciences.

[19]  G. Granger,et al.  The human LT system. VIII. A target cell-dependent enzymatic activation step required for the expression of the cytotoxic activity of human lymphotoxin. , 1980, Journal of immunology.

[20]  G. Berke.  Interaction of cytotoxic T lymphocytes and target cells. , 1980, Progress in allergy.

[21]  G. Kaplan,et al.  Role of activated macrophages in antibody-dependent lysis of tumor cells , 1980, The Journal of experimental medicine.

[22]  C. Nathan,et al.  Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages , 1980, The Journal of experimental medicine.

[23]  A. Allison,et al.  Cytolysis of fibroblasts by C3a. , 1980, British Journal of Cancer.

[24]  J. Roder,et al.  Chediak-Higashi gene in humans. I. Impairment of natural - killer function , 1980, The Journal of experimental medicine.

[25]  D. Redelman,et al.  The mechanism of cell-mediated cytotoxicity. I. Killing by murine cytotoxic T lymphocytes requires cell surface thiols and activated proteases. , 1980, Journal of immunology.

[26]  J. Hibbs,et al.  Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. , 1980, The Journal of clinical investigation.

[27]  D. Adams.  Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. , 1980, Journal of immunology.

[28]  S. Pizzo,et al.  Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. , 1980, Journal of immunology.

[29]  R. Herberman.  Natural cell-mediated immunity against tumors , 1980 .

[30]  F. Takaku,et al.  Evidence that proteases are involved in superoxide production by human polymorphonuclear leukocytes and monocytes. , 1980, The Journal of clinical investigation.

[31]  F. Takaku,et al.  Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents , 1979, FEBS letters.

[32]  E. Saksela,et al.  Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. , 1979, Cellular immunology.

[33]  H. Kikutani,et al.  Involvement of anti-Ig-activated serine protease in the generation of cytoplasmic factor(s) that are responsible for the transmission of Ig-receptor-mediated signals. , 1979, Journal of immunology.

[34]  H. Chapman,et al.  Modulation of plasminogen activator secretion by activated macrophages: influence of serum factors and correlation with tumoricidal potential. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[35]  B. Goldstein,et al.  Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption. , 1979, Biochemical and biophysical research communications.

[36]  J. Roder,et al.  The beige mutation in the mouse selectively impairs natural killer cell function , 1979, Nature.

[37]  J. Roder,et al.  Target-effector interaction in the natural killer cell system: isolation of target structures. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Y. Kobayashi,et al.  Activation of membrane phospholipase A by guinea pig lymphotoxin (GLT). , 1979, Journal of immunology.

[39]  C. Nathan,et al.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity , 1979, The Journal of experimental medicine.

[40]  C. Nathan,et al.  Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity , 1979, The Journal of experimental medicine.

[41]  C. Ware,et al.  Cytotoxic and Growth Inhibitory Lymphokines , 1979 .

[42]  Z. Ballas,et al.  The Relationship between Lymphokines and Cell-Mediated Cytotoxicity , 1979 .

[43]  J. Roder,et al.  Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. , 1978, Journal of immunology.

[44]  R. Goldfarb,et al.  Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts. , 1978, Cancer research.

[45]  S. Sharma,et al.  Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. II. Inhibition by inhibitors of protein synthesis. , 1978, Cellular immunology.

[46]  J. Maillard,et al.  Stimulated lymph node lymphocytes release a plasminogen activator. , 1978, Annales d'immunologie.

[47]  C. Griscelli,et al.  Specific protease deficiency in polymorphonuclear leukocytes of Chediak- Higashi syndrome and beige mice , 1978, The Journal of experimental medicine.

[48]  A. Grayzel,et al.  A cytotoxic proteinase isolated from human lymphocytes. , 1978, Journal of immunology.

[49]  R. Goldfarb,et al.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Barrett.  Proteinases in Mammalian Cells and Tissues , 1977 .

[51]  D. Lucas.  Regulatory mechanisms in lymphocyte activation , 1977 .

[52]  E. Martz.  Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes: resolution and characterization of discrete steps in the cellular interaction. , 1977, Contemporary topics in immunobiology.

[53]  P. Golstein,et al.  Mechanism of T-cell-mediated cytolysis: the lethal hit stage. , 1977, Contemporary topics in immunobiology.

[54]  C. Henney,et al.  T-Cell-mediated cytolysis: an overview of some current issues. , 1977, Contemporary topics in immunobiology.

[55]  G. Trinchieri,et al.  Antibody-dependent cell-mediated cytotoxicity in humans. III. Effect of protease inhibitors and substrates. , 1976, Journal of immunology.

[56]  H. Peter,et al.  Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator. , 1976, Journal of immunology.

[57]  Z. Tökés.  Estimation of cell surface associated protease activity and its application to lymphocytes. , 1976, Journal of supramolecular structure.

[58]  L. Frye,et al.  Inhibition of mammalian cytotoxic cells by phosphatidylcholine and its analogue , 1975, Nature.

[59]  G. Trinchieri,et al.  Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell. , 1975, Journal of immunology.

[60]  A. Matter.  A Study of Proteolysis as a Possible Mechanism for T‐Cell‐Mediated Target Cell Lysis , 1975, Scandinavian journal of immunology.

[61]  R. Clark,et al.  Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system , 1975, The Journal of experimental medicine.

[62]  A. Einstein,et al.  Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells. , 1975, Blood.

[63]  J. Ferluga,et al.  Observations on the mechanism by which T-lymphocytes exert cytotoxic effects , 1974, Nature.

[64]  J. Unkeless,et al.  SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES , 1974, The Journal of experimental medicine.

[65]  J. Fahey,et al.  Enzymatic enhancement of cell-mediated cytotoxicity and antibody-dependent cell cytotoxicity. , 1974, Journal of immunology.

[66]  I. Bernstein.  Immunologic defenses against cancer. , 1973, The Journal of pediatrics.

[67]  G. Asherson,et al.  The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking. , 1972, Immunology.